<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34770758</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>06</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1420-3049</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>26</Volume>
            <Issue>21</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Oct</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Molecules (Basel, Switzerland)</Title>
          <ISOAbbreviation>Molecules</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Hydrolysis and Enantiodiscrimination of (<i>R</i>)- and (<i>S</i>)-Oxazepam Hemisuccinate by Methylated β-Cyclodextrins: An NMR Investigation.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">6347</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/molecules26216347</ELocationID>
        <Abstract>
          <AbstractText>Partially and exhaustively methylated β-cyclodextrins [(2-methyl)-β-CD (MCD), heptakis-(2,6-di-<i>O</i>-methyl)-β-CD (DIMEB), and heptakis-(2,3,6-tri-<i>O</i>-methyl)-β-CD (TRIMEB)] have been compared in the hydrolysis and enantiodiscrimination of benzodiazepine derivative (<i>R</i>)- or (<i>S</i>)-oxazepam hemisuccinate (OXEMIS), using nuclear magnetic resonance (NMR) spectroscopy as an investigation tool. After 6 h, MCD induced an 11% hydrolysis of OXEMIS, remarkably lower in comparison with underivatized β-CD (48%), whereas no hydrolysis was detected in the presence of DIMEB or TRIMEB after 24 h. DIMEB showed greater ability to differentiate OXEMIS enantiomers in comparison to TRIMEB, by contrast MCD did not produce any splitting of racemic OXEMIS resonances. Both enantiomers of OXEMIS underwent deep inclusion of their phenyl pendant into cyclodextrins cavities from their wider rims, but tighter complexes were formed by DIMEB with respect to TRIMEB.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Cesari</LastName>
            <ForeName>Andrea</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-9927-0953</Identifier>
            <AffiliationInfo>
              <Affiliation>Dipartimento di Scienze Chimiche, Università di Padova, Via Marzolo 1, 35131 Padova, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Balzano</LastName>
            <ForeName>Federica</ForeName>
            <Initials>F</Initials>
            <Identifier Source="ORCID">0000-0001-6916-321X</Identifier>
            <AffiliationInfo>
              <Affiliation>Dipartimento di Chimica e Chimica Industriale, Università di Pisa, Via Moruzzi 13, 56124 Pisa, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Uccello Barretta</LastName>
            <ForeName>Gloria</ForeName>
            <Initials>G</Initials>
            <Identifier Source="ORCID">0000-0001-6735-2711</Identifier>
            <AffiliationInfo>
              <Affiliation>Dipartimento di Chimica e Chimica Industriale, Università di Pisa, Via Moruzzi 13, 56124 Pisa, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Recchimurzo</LastName>
            <ForeName>Alessandra</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0001-9907-6117</Identifier>
            <AffiliationInfo>
              <Affiliation>Dipartimento di Chimica e Chimica Industriale, Università di Pisa, Via Moruzzi 13, 56124 Pisa, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Molecules</MedlineTA>
        <NlmUniqueID>100964009</NlmUniqueID>
        <ISSNLinking>1420-3049</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D047392">beta-Cyclodextrins</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>6GOW6DWN2A</RegistryNumber>
          <NameOfSubstance UI="D010076">Oxazepam</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>DCE8700INN</RegistryNumber>
          <NameOfSubstance UI="C023857">oxazepam hemisuccinate</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D006868" MajorTopicYN="N">Hydrolysis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009682" MajorTopicYN="Y">Magnetic Resonance Spectroscopy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008745" MajorTopicYN="N">Methylation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008958" MajorTopicYN="N">Models, Molecular</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010076" MajorTopicYN="N">Oxazepam</DescriptorName>
          <QualifierName UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D047392" MajorTopicYN="N">beta-Cyclodextrins</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">NMR</Keyword>
        <Keyword MajorTopicYN="N">benzodiazepines</Keyword>
        <Keyword MajorTopicYN="N">chiral discrimination</Keyword>
        <Keyword MajorTopicYN="N">hydrolysis</Keyword>
        <Keyword MajorTopicYN="N">inclusion complexes</Keyword>
        <Keyword MajorTopicYN="N">methylated cyclodextrins</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>9</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>13</Day>
          <Hour>1</Hour>
          <Minute>12</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>14</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34770758</ArticleId>
        <ArticleId IdType="pmc">PMC8587842</ArticleId>
        <ArticleId IdType="doi">10.3390/molecules26216347</ArticleId>
        <ArticleId IdType="pii">molecules26216347</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Griffin C.E., III, Kaye A.M., Kaye A.D. Benzodiazepine Pharmacology and Central Nervous System–Mediated Effects. Ochsner J. 2013;13:214–223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3684331</ArticleId>
            <ArticleId IdType="pubmed">23789008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schmitz A. Benzodiazepine Use, Misuse, and Abuse: A Review. Ment. Health Clin. 2016;6:120–126. doi: 10.9740/mhc.2016.05.120.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.9740/mhc.2016.05.120</ArticleId>
            <ArticleId IdType="pmc">PMC6007645</ArticleId>
            <ArticleId IdType="pubmed">29955458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pham-Huy C., Villain-Pautet G., Hua H., Chikhi-Chorfi N., Galons H., Thevenin M., Claude J.-R., Warnet J.-M. Separation of oxazepam, lorazepam, and temazepam enantiomers by HPLC on a derivatized cyclodextrin-bonded phase: Application to the determination of oxazepam in plasma. J. Biochem. Biophys. Methods. 2002;54:287–299. doi: 10.1016/S0165-022X(02)00123-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0165-022X(02)00123-9</ArticleId>
            <ArticleId IdType="pubmed">12543505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Court M.H., Duan S.X., Guillemette C., Journault K., Krishnaswamy S., Von Moltke L.L., Greenblatt D.J. Stereoselective Conjugation of Oxazepam by Human UDP-Glucuronosyltransferases (UGTs): S-Oxazepam Is Glucuronidated by UGT2B15, while R-Oxazepam Is Glucuronidated by UGT2B7 and UGT1A9. Drug Metab. Dispos. 2002;30:1257–1265. doi: 10.1124/dmd.30.11.1257.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1124/dmd.30.11.1257</ArticleId>
            <ArticleId IdType="pubmed">12386133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel M., Tang B.K., Grant D.M., Kalow W. Interindividual variability in the glucuronidation of (S) oxazepam contrasted with that of (R) oxazepam. Pharmacogenetics. 1995;5:287–297. doi: 10.1097/00008571-199510000-00004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00008571-199510000-00004</ArticleId>
            <ArticleId IdType="pubmed">8563769</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Uchaipichat V., Suthisisang C., Miners J.O. The Glucuronidation of R- and S-Lorazepam: Human Liver Microsomal Kinetics, UDP-Glucuronosyltransferase Enzyme Selectivity, and Inhibition by Drugs. Drug Metab. Dispos. 2013;41:1273–1284. doi: 10.1124/dmd.113.051656.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1124/dmd.113.051656</ArticleId>
            <ArticleId IdType="pubmed">23554428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patel M., Tang B.K., Kalow W. (S)Oxazepam glucuronidation is inhibited by Ketoprofen and other substrates of UGT2B7. Pharmacogenetics. 1995;5:43–49. doi: 10.1097/00008571-199502000-00005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00008571-199502000-00005</ArticleId>
            <ArticleId IdType="pubmed">7773302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nguyen L.A., He H., Pham-Huy C. Chiral drugs: An overview. Int. J. Biomed. Sci. 2006;2:85–100.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3614593</ArticleId>
            <ArticleId IdType="pubmed">23674971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hok L., Božičević L., Sremec H., Šakić D., Vrček V. Racemization of oxazepam and chiral 1,4-benzodiazepines. DFT study of the reaction mechanism in aqueous solution. Org. Biomol. Chem. 2019;17:1471–1479. doi: 10.1039/C8OB02991A.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1039/C8OB02991A</ArticleId>
            <ArticleId IdType="pubmed">30676597</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang S.K., Lu X.-L. Racemization Kinetics of Enantiomeric Oxazepams and Stereoselective Hydrolysis of Enantiomeric Oxazepam 3-Acetates in Rat Liver Microsomes and Brain Homogenate. J. Pharm. Sci. 1989;78:789–795. doi: 10.1002/jps.2600781002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jps.2600781002</ArticleId>
            <ArticleId IdType="pubmed">2600781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maksay G., Tegyey Z., Kemeny V., Lukovits I., Otvos L., Palosi E. Oxazepam esters. 1. Correlation between hydrolysis rates and brain appearance of oxazepam. J. Med. Chem. 1979;22:1436–1443. doi: 10.1021/jm00198a002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/jm00198a002</ArticleId>
            <ArticleId IdType="pubmed">536988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cassano T., Lopalco A., de Candia M., Laquintana V., Lopedota A., Cutrignelli A., Perrone M., Iacobazzi R.M., Bedse G., Franco M., et al.  Oxazepam–Dopamine Conjugates Increase Dopamine Delivery into Striatum of Intact Rats. Mol. Pharm. 2017;14:3178–3187. doi: 10.1021/acs.molpharmaceut.7b00405.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/acs.molpharmaceut.7b00405</ArticleId>
            <ArticleId IdType="pubmed">28780872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bertucci C., Domenici E., Uccello-Barretta G., Salvadori P. High-performance liquid chromatographic resolution of racemic 1,4-benzodiazepin-2-ones by means of a β-cyclodextrin silica bonded chiral stationary phase. J. Chromatogr. A. 1990;506:617–625. doi: 10.1016/S0021-9673(01)91610-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0021-9673(01)91610-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Szente L., Szemán J. Cyclodextrins in Analytical Chemistry: Host–Guest Type Molecular Recognition. Anal. Chem. 2013;85:8024–8030. doi: 10.1021/ac400639y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/ac400639y</ArticleId>
            <ArticleId IdType="pubmed">23786163</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kfoury M., Landy D., Fourmentin S. Characterization of Cyclodextrin/Volatile Inclusion Complexes: A Review. Molecules. 2018;23:1204.  doi: 10.3390/molecules23051204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules23051204</ArticleId>
            <ArticleId IdType="pmc">PMC6100373</ArticleId>
            <ArticleId IdType="pubmed">29772824</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morin-Crini N., Fourmentin S., Fenyvesi E., Lichtfouse E., Torri G., Fourmentin M., Crini G. 130 years of cyclodextrin discovery for health, food, agriculture, and the industry: A review. Environ. Chem. Lett. 2021;19:2581–2617. doi: 10.1007/s10311-020-01156-w.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10311-020-01156-w</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee J.-U., Lee S.-S., Lee S., Bin Oh H. Noncovalent Complexes of Cyclodextrin with Small Organic Molecules: Applications and Insights into Host–Guest Interactions in the Gas Phase and Condensed Phase. Molecules. 2020;25:4048.  doi: 10.3390/molecules25184048.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules25184048</ArticleId>
            <ArticleId IdType="pmc">PMC7571109</ArticleId>
            <ArticleId IdType="pubmed">32899713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Periasamy R. Cyclodextrin-based molecules as hosts in the formation of supramolecular complexes and their practical ap-plications—A review. J. Carbohydr. Chem. 2021:135–155. doi: 10.1080/07328303.2021.1967970.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/07328303.2021.1967970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chankvetadze B. Application of enantioselective separation techniques to bioanalysis of chiral drugs and their metabolites. TrAC Trends Anal. Chem. 2021;143:116332. doi: 10.1016/j.trac.2021.116332.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.trac.2021.116332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alvarez-Rivera G., Bueno M., Vivas D.B., Cifuentes A. Chiral analysis in food science. Trends Anal. Chem. 2019;123:115761. doi: 10.1016/j.trac.2019.115761.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.trac.2019.115761</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Juvancz Z., Bodáné-Kendrovics R., Szente L., Maklári D. Cyclodextrins as Dominant Chiral Selective Agents in the Capillary Separation Techniques. Period. Polytech. Chem. Eng. 2021;65:580–594. doi: 10.3311/PPch.18067.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3311/PPch.18067</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scriba G.K. Chiral recognition in separation sciences: Part I: Polysaccharide and cyclodextrin selectors. Trends Anal. Chem. 2019;120:115639. doi: 10.1016/j.trac.2019.115639.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.trac.2019.115639</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hancu G., Papp L., Tóth G., Kelemen H. The Use of Dual Cyclodextrin Chiral Selector Systems in the Enantioseparation of Pharmaceuticals by Capillary Electrophoresis: An Overview. Molecules. 2021;26:2261.  doi: 10.3390/molecules26082261.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/molecules26082261</ArticleId>
            <ArticleId IdType="pmc">PMC8069766</ArticleId>
            <ArticleId IdType="pubmed">33919692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo C., Xiao Y. Negatively charged cyclodextrins: Synthesis and applications in chiral analysis-A review. Carbohydr. Polym. 2020;256:117517. doi: 10.1016/j.carbpol.2020.117517.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.carbpol.2020.117517</ArticleId>
            <ArticleId IdType="pubmed">33483038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gunjal P., Singh S.K., Kumar R., Kumar R., Gulati M. Role of Chromatograph-based Analytical Techniques in Quantification of Chiral Compounds: An Update. Curr. Anal. Chem. 2021;17:355–373. doi: 10.2174/1573411016999200525144506.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/1573411016999200525144506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang S.-Y., Li L., Xiao Y., Wang Y. Recent advances in cyclodextrins-based chiral-recognizing platforms. Trends Anal. Chem. 2019;121:115691. doi: 10.1016/j.trac.2019.115691.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.trac.2019.115691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wenzel T.J.  Differentiation of Chiral Compounds Using NMR Spectroscopy. 2nd ed. John Wiley &amp; Sons; Hoboken, NJ, USA: 2018. </Citation>
        </Reference>
        <Reference>
          <Citation>Balzano F., Uccello-Barretta G., Aiello F.  Chiral Analysis by NMR Spectroscopy: Chiral Solvating Agents. In: Polavarapu P.L., editor. Chiral Analysis: Advances in Spectroscopy, Chromatography and Emerging Methods. Elsevier; Amsterdam, The Netherlands: 2018. pp. 367–427.</Citation>
        </Reference>
        <Reference>
          <Citation>Chin T.-F., Chung P.-H., Lach J.L. Influence of Cyclodextrins on Ester Hydrolysis. J. Pharm. Sci. 1968;57:44–48. doi: 10.1002/jps.2600570109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jps.2600570109</ArticleId>
            <ArticleId IdType="pubmed">5661767</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Popielec A., Loftsson T. Effects of cyclodextrins on the chemical stability of drugs. Int. J. Pharm. 2017;531:532–542. doi: 10.1016/j.ijpharm.2017.06.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijpharm.2017.06.009</ArticleId>
            <ArticleId IdType="pubmed">28596139</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trotta F., Moraglio G., Rapposelli A. The effect of cyclodextrins on the hydrolysis of carboxylic acid esters. J. Incl. Phenom. Macrocycl. Chem. 1994;20:353–361. doi: 10.1007/BF00708879.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF00708879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cesari A., Piras A.M., Zambito Y., Barretta G.U., Balzano F. 2-Methyl-β-cyclodextrin grafted ammonium chitosan: Synergistic effects of cyclodextrin host and polymer backbone in the interaction with amphiphilic prednisolone phosphate salt as revealed by NMR spectroscopy. Int. J. Pharm. 2020;587:119698. doi: 10.1016/j.ijpharm.2020.119698.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijpharm.2020.119698</ArticleId>
            <ArticleId IdType="pubmed">32736017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Homer J., Perry M.C. Molecular complexes: Part 18—A nuclear magnetic resonance adaptation of the continuous variation (job) method of stoicheiometry determination. J. Chem. Soc. Faraday Trans. 1 Phys. Chem. Condens. Phases. 1986;82:533–543. doi: 10.1039/f19868200533.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1039/f19868200533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foster R., Fyfe C.A. Interaction of electron acceptors with bases: Part 15—Determination of association constants of organic charge-transfer complexes by n.m.r. spectroscopy. Trans. Faraday Soc. 1965;61:1626–1631. doi: 10.1039/TF9656101626.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1039/TF9656101626</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
